These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 13587040)

  • 21. The adsorption of heterologous desoxyribonucleic acid by Novikoff hepatoma cells.
    WILCZOK T
    Neoplasma; 1961; 8():453-62. PubMed ID: 14006951
    [No Abstract]   [Full Text] [Related]  

  • 22. Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptor.
    Savkur RS; Bramlett KS; Michael LF; Burris TP
    Biochem Biophys Res Commun; 2005 Apr; 329(1):391-6. PubMed ID: 15721319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some peculiar biological and biochemical properties of a mouse hepatoma induced by chrysoidin. II. Metabolic properties of the hepatoma.
    ALBERT Z; ORLOWSKI M
    J Natl Cancer Inst; 1960 Sep; 25():455-60. PubMed ID: 13682110
    [No Abstract]   [Full Text] [Related]  

  • 24. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [On the respiration and glycolysis of Ehrlich ascites tumor cells].
    SHYNN YS
    Chosen Ibo; 1962 Oct; 7():781-4. PubMed ID: 13988840
    [No Abstract]   [Full Text] [Related]  

  • 26. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.
    Díaz-Troya S; Najib S; Sánchez-Margalet V
    Regul Pept; 2005 Feb; 125(1-3):41-6. PubMed ID: 15582712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocorticoid protects hepatoma cells against metabolic stress-induced cell death.
    Uen YH; Ko PH; Yin PH; Liu TY; Chi CW; Lui WY
    Int J Oncol; 2008 Dec; 33(6):1263-70. PubMed ID: 19020760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative proteomics of rat liver and Morris hepatoma 7777 plasma membranes.
    Clifton JG; Li X; Reutter W; Hixson DC; Josic D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):293-301. PubMed ID: 16987716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
    Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
    Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
    Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
    Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis.
    Kar S; Wang M; Carr BI
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):831-40. PubMed ID: 18246350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic expression of human hepatoma cells in culture.
    Cutroneo KR; White SL; Buttolph TR; Allison G; Ehrlich HP
    J Cell Biochem; 2007 Apr; 100(5):1081-5. PubMed ID: 17295205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the growth-promoting substances for rat ascites hepatoma cells in tissue culture.
    KATSUTA H; TAKAOKA T; HORI M; SAITO S; SUZUKI S; SOMEYA Y; ITO E
    Jpn J Exp Med; 1958 Jun; 28(3):199-212. PubMed ID: 13575003
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of chlorpromazine, penthiobarbital and soneryl on glycolysis by the cells of a rat ascitic hepatoma].
    ANDREJEW A; ROSENBENG AJ
    C R Seances Soc Biol Fil; 1957; 151(2):237-40. PubMed ID: 13473225
    [No Abstract]   [Full Text] [Related]  

  • 35. Glucose supply by the living host and glycolysis of Yoshida ascites hepatoma in vivo.
    DEL MONTE U; ROSSI CB
    Cancer Res; 1963 Mar; 23():363-7. PubMed ID: 14026560
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of aerobic glycolysis in Yoshida ascites hepatoma by tartronic acid.
    FIUME L
    Nature; 1960 Aug; 187():792-3. PubMed ID: 13823333
    [No Abstract]   [Full Text] [Related]  

  • 37. On the carbohydrate metabolism of rat ascites hepatoma cells in tissue culture.
    HORI M; TAKAOKA T; KATSUTA H
    Jpn J Exp Med; 1958 Aug; 28(4):259-88. PubMed ID: 13587040
    [No Abstract]   [Full Text] [Related]  

  • 38. Glucose metabolism of rat ascites hepatoma cells (strain no. 2) in tissue culture.
    KUWABARA S
    Jpn J Exp Med; 1959 Oct; 29():571-84. PubMed ID: 14413002
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.